Analyze Diet
Journal of veterinary pharmacology and therapeutics2008; 31(1); 39-44; doi: 10.1111/j.1365-2885.2007.00925.x

Effects of single-dose intravenous phenylbutazone on experimentally induced, reversible lameness in the horse.

Abstract: The objective was to test the hypothesis that phenylbutazone (PBZ) alleviates lameness in an adjustable heart bar shoe model of equine foot pain. Eight Quarter Horse mares underwent 4-weekly treatments randomly: 0.9% saline placebo (SAL: 1 mL/45 kg body weight i.v.) with no lameness; SAL with lameness; PBZ (4.4 mg/kg body weight i.v.) with no lameness; and PBZ with lameness. Blinded heart rate (HR) and lameness score (LS) were assessed every 20 min for 2 h and then hourly through 9 h. At 1 h SAL or PBZ was administered. Jugular venous samples were obtained at hours 0, 1, 2, 4, 6, and 8 and were evaluated for packed cell volume (PCV), cortisol, and drug concentrations. Repeated measures anova and t-tests were used to identify PBZ effects at a significance level of P<0.05. PBZ-treated LS was lower 2-8 h post-treatment, and HR was lower from 2 through 6 h post-treatment (P<0.05). Phenylbutazone did not change PCV and had minimal effect on cortisol. Mean plasma PBZ and oxyphenbutazone concentrations 7 h after treatment were 7.2-7.5 and 1.6-1.9 microg/mL, respectively. It was concluded that PBZ was efficacious in alleviating lameness in this model. Cortisol and PCV were not discriminating enough to distinguish between PBZ-treated and SAL-treated trials.
Publication Date: 2008-01-08 PubMed ID: 18177317DOI: 10.1111/j.1365-2885.2007.00925.xGoogle Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article
  • Randomized Controlled Trial

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research examines the effects of a single dose of phenylbutazone, a nonsteroidal anti-inflammatory drug, on horses suffering from adjustable heart bar shoe-induced lameness. It was found that phenylbutazone was efficient in alleviating lameness and controlling heart rate, without significant effects on packed cell volume and cortisol levels.

Research Context and Objective

  • This study aimed to explore the impact of phenylbutazone (PBZ), an anti-inflammatory drug, on lameness in horses caused by an adjustable heart bar shoe. This lameness is a reversible condition often used as a model for equine foot pain.
  • The hypothesis being tested was that PBZ could provide relief for this kind of lameness.

Methodology

  • An experiment was conducted involving eight Quarter Horse mares. These mares underwent four different treatment scenarios on a random basis, involving a combination of either PBZ or a saline placebo, and either with or without the presence of lameness.
  • Heart rates and lameness scores were recorded at varying intervals over a nine-hour period, during which the treatment (PBZ or placebo) was administered at the first hour.
  • Moreover, samples were taken from the jugular veins at designated hours and were analyzed for various indicators such as packed cell volume (PCV), cortisol, and drug concentrations.
  • Data analyses were employed to identify any observable effects of PBZ on the chosen indicators.

Results

  • PBZ was found to have lowered lameness scores from the second to the eighth hour post administration, and also reduced heart rates from the second through the sixth hour.
  • It was found not to have significantly altered PCV and had a minimal impact on cortisol levels.
  • The mean plasma concentrations of PBZ seven hours after administration was recorded between 7.2 and 7.5 micrograms per milliliter.

Conclusion

  • The study concluded that PBZ was truly effective in relieving equine lameness induced by an adjustable heart bar shoe model.
  • However, it was found that cortisol and PCV levels were not sensitive enough to distinguish between horses that received PBZ and those that were given the saline placebo.

Cite This Article

APA
Foreman JH, Barange A, Lawrence LM, Hungerford LL. (2008). Effects of single-dose intravenous phenylbutazone on experimentally induced, reversible lameness in the horse. J Vet Pharmacol Ther, 31(1), 39-44. https://doi.org/10.1111/j.1365-2885.2007.00925.x

Publication

ISSN: 0140-7783
NlmUniqueID: 7910920
Country: England
Language: English
Volume: 31
Issue: 1
Pages: 39-44

Researcher Affiliations

Foreman, J H
  • Department of Veterinary Clinical Medicine, University of Illinois at Urbana-Champaign, Urbana, IL 61802, USA. jhf@uiuc.edu
Barange, A
    Lawrence, L M
      Hungerford, L L

        MeSH Terms

        • Animals
        • Anti-Inflammatory Agents, Non-Steroidal / administration & dosage
        • Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
        • Female
        • Forelimb / injuries
        • Heart Rate
        • Horses / injuries
        • Hydrocortisone / blood
        • Injections, Intravenous / veterinary
        • Injury Severity Score
        • Lameness, Animal
        • Pain / prevention & control
        • Pain / veterinary
        • Pain Measurement / veterinary
        • Phenylbutazone / administration & dosage
        • Phenylbutazone / therapeutic use
        • Treatment Outcome

        Citations

        This article has been cited 7 times.
        1. Mercer MA, Davis JL, McKenzie HC. The Clinical Pharmacology and Therapeutic Evaluation of Non-Steroidal Anti-Inflammatory Drugs in Adult Horses. Animals (Basel) 2023 May 10;13(10).
          doi: 10.3390/ani13101597pubmed: 37238029google scholar: lookup
        2. Flood J, Stewart AJ. Non-Steroidal Anti-Inflammatory Drugs and Associated Toxicities in Horses. Animals (Basel) 2022 Oct 26;12(21).
          doi: 10.3390/ani12212939pubmed: 36359062google scholar: lookup
        3. Jacobs CC, Schnabel LV, McIlwraith CW, Blikslager AT. Non-steroidal anti-inflammatory drugs in equine orthopaedics. Equine Vet J 2022 Jan 25;54(4):636-48.
          doi: 10.1111/evj.13561pubmed: 35076950google scholar: lookup
        4. Gehlen H, Jaburg N, Merle R, Winter J. Can Endocrine Dysfunction Be Reliably Tested in Aged Horses That Are Experiencing Pain?. Animals (Basel) 2020 Aug 14;10(8).
          doi: 10.3390/ani10081426pubmed: 32824027google scholar: lookup
        5. Moser DK, Schoonover MJ, Sippel KM, Dieterly AM, Ritchey JW, Wall CR. Catastrophic complication following injection and extracorporeal shock wave therapy of a medial femoral condyle subchondral cystic lesion in a 14 year old Arabian mare. Open Vet J 2017;7(2):111-116.
          doi: 10.4314/ovj.v7i2.6pubmed: 28616392google scholar: lookup
        6. Banse H, Cribb AE. Comparative efficacy of oral meloxicam and phenylbutazone in 2 experimental pain models in the horse. Can Vet J 2017 Feb;58(2):157-167.
          pubmed: 28216685
        7. Gigliuto C, De Gregori M, Malafoglia V, Raffaeli W, Compagnone C, Visai L, Petrini P, Avanzini MA, Muscoli C, Viganò J, Calabrese F, Dominioni T, Allegri M, Cobianchi L. Pain assessment in animal models: do we need further studies?. J Pain Res 2014;7:227-36.
          doi: 10.2147/JPR.S59161pubmed: 24855386google scholar: lookup